Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Imunon, Inc. Director's Dealing 2012

Sep 14, 2012

35124_dirs_2012-09-14_2674f7e6-2510-4e10-ab82-a85c39ce0488.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2012-09-14

Reporting Person: Tardugno Michael H (CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-09-14 Celsion Corporation Common Stock P 3100 $5.03 Acquired 194114 Direct
2012-09-14 Celsion Corporation Common Stock P 1900 $5.04 Acquired 196014 Direct

Footnotes

F1: The shares of common stock were purchased by the officer on the open market.